Clinical Trial Update: Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing GEMOX to XELOX in advanced biliary tract cancer; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• GemOx (gemcitabine + oxaliplatin) (gemcitabine and oxaliplatin)
• XELOX (Xeloda/Oxaliplatin) (Capecitabine; Oxaliplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer | Phase 3 | Status: UNKNOWN